3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
27
Neoplasms
25
Lung Neoplasms
12
Uterine Cervical Neoplasms
11
Colorectal Neoplasms
10
Colonic Neoplasms
8
Motor Activity
7
Urinary Bladder Neoplasms
6
Rectal Neoplasms
6
Vulvar Neoplasms
5
Obesity
5
Endometrial Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Melanoma
4
Head and Neck Neoplasms
4
Anxiety Disorders
4
Stomach Neoplasms
3
Sarcoma
3
Prostatic Neoplasms
3
Papillomavirus Infections
3
Lymphoma
3
Hematopoietic and Lymphoid System Neoplasm
3
Hematologic Neoplasms
3
Depression
3
Carcinoma, Ovarian Epithelial
3
Breast Carcinoma In Situ
3
Vaginal Neoplasms
2
Testicular Neoplasms
2
Smoking Cessation
2
Skin Neoplasms
2
Interventions
padeliporfin
4
Nivolumab
4
Gemcitabine
4
Cyclophosphamide
4
130-nm albumin-bound paclitaxel
4
napabucasin
3
Pemetrexed
3
Fluorouracil
3
Albumin-Bound Paclitaxel
3
ficlatuzumab
2
Trastuzumab
2
Trabectedin
2
Paclitaxel
2
Leucovorin
2
Irinotecan
2
Bevacizumab
2
sotorasib
1
selinexor
1
ribociclib
1
relatlimab
1
pralsetinib
1
pembrolizumab
1
pamiparib
1
osimertinib
1
nintedanib
1
ipatasertib
1
guadecitabine
1
glutathione pegylated liposomal doxorubicin
1
exemestane
1
entinostat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Neoplasms by Site
×
Methods
×
Clear all
NCT03569605
2021-04-01
IMPACT
UNC Lineberger Comprehensive Cancer Center
Phase NA
Completed
280 enrolled